Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
745 INR | -0.41% |
|
-2.54% | -29.14% |
May. 21 | Transcript : Anupam Rasayan India Limited, Q4 2024 Earnings Call, May 21, 2024 | |
May. 20 | Anupam Rasayan India's Consolidated Net Profit Declines in Fiscal Q4 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 60.49 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.14% | 982M | C+ | ||
+22.97% | 69.47B | A- | ||
-4.09% | 46.2B | A- | ||
+25.52% | 44.48B | B+ | ||
+38.40% | 29.65B | A- | ||
+13.95% | 19.9B | C+ | ||
+14.66% | 17.23B | B+ | ||
-10.93% | 14.71B | B+ | ||
-28.13% | 14.45B | A- | ||
-29.43% | 11.89B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ANURAS Stock
- ANURAS Stock
- Ratings Anupam Rasayan India Limited